Tuesday, March 11, 2008

encyclopedia britannica

Parkinson's disease is a motor disorder characterized by the onset of a “pill rolling” rhythmic tremor, muscle rigidity, difficulty and slowness in movement, and stooped posture. As the disease progresses, the face of the patient becomes expressionless, the rate of swallowing is reduced, leading to drooling, and depression and dementia increase. The prevalence of Parkinson's disease is estimated to be about 187 per 100,000 persons in the general population, with about 20 new cases per 100,000 appearing each year. Men are slightly more affected than women, and there are no apparent racial differences. The disease appears typically in the sixth and seventh decades, although occasionally it can begin as early as the third decade. While the majority of cases of Parkinson's disease are of unknown cause, the disease was linked to a complication of encephalitis that developed following the worldwide outbreak of influenza during World War I and, more recently, to an episode of use by intravenous drug abusers of a synthetic drug similar to heroin. A marked decrease in the level of dopamine, a major neurotransmitter, has been noted in the brains of patients with Parkinson's disease, and this change has been attributed to the loss of so-called dopaminergic neurons that normally synthesize and use dopamine to communicate with other neurons in parts of the brain that regulate motor function. This information has opened a new approach to the treatment of the disease—namely, administration of the metabolic precursor to dopamine (L-dopa) that can be converted by the body to dopamine. Although initially beneficial in causing a significant remission of symptoms, L-dopa frequently is effective for only 5 to 10 years, and serious side effects accompany treatment. Cotreatment with an inhibitor of the enzyme that breaks down L-dopa and thus allows the substance to remain in the brain longer has yielded an effective therapy, which allows many patients to live reasonably normal lives. Treatment of the disease with fetal tissue transplants, while raising ethical and legal issues, also has shown promise in alleviating symptoms. Nevertheless, although treatment may slow the progress of the disease, it does not alter its course. This suggests that factors other than variation in neurotransmitter levels are responsible for the disease.

No comments: